Orchid Chemicals to acquire U.S. pharma firm

Thursday, 30 October 2008, 07:00 Hrs
Printer Print Email Email
Chennai: The city-based bulk drug major Orchid Chemicals and Pharmaceuticals will increase its stake in the American drug discovery and development company Diakron Inc to 51 percent this quarter.

In August, the company acquired around 43 percent control in Diakron on an investment of $1.7 million.

According to an Orchid official, the Indian company will now acquire a controlling interest on a total investment of $2 million.

Orchid Chemicals closed the first half of this fiscal with a revenue of 6.54 billion and a net loss of 723 million, as against 5.29 billion in earnings and 1.14 billion in profits during the corresponding period the previous year.
Source: IANS
Fossil Group sells smartwatch
Global watch and accessories maker Fossil Group has announced to sell its smartphone technolog..
GST rate cut to spur Bengaluru
The realty market in India's tech hub is set to grow as lower Goods and Services Tax (GST) rate..
Ola raises Rs 400 cr for electric
Leading ride-hailing cab aggregator Ola on Friday said it raised Rs 400 crore from its early in..
SpiceJet plans aggressive
Budget passenger carrier SpiceJet plans to aggressively expand its international networks to fl..